175 related articles for article (PubMed ID: 37124725)
1. CCL17 and CCL22 chemokines are upregulated in human obesity and play a role in vascular dysfunction.
Hueso L; Marques P; Morant B; Gonzalez-Navarro H; Ortega J; Real JT; Sanz MJ; Piqueras L
Front Endocrinol (Lausanne); 2023; 14():1154158. PubMed ID: 37124725
[TBL] [Abstract][Full Text] [Related]
2. Dominance of CCL22 over CCL17 in induction of chemokine receptor CCR4 desensitization and internalization on human Th2 cells.
Mariani M; Lang R; Binda E; Panina-Bordignon P; D'Ambrosio D
Eur J Immunol; 2004 Jan; 34(1):231-40. PubMed ID: 14971049
[TBL] [Abstract][Full Text] [Related]
3. Macrophage derived chemokine (CCL22), thymus and activation-regulated chemokine (CCL17), and CCR4 in idiopathic pulmonary fibrosis.
Yogo Y; Fujishima S; Inoue T; Saito F; Shiomi T; Yamaguchi K; Ishizaka A
Respir Res; 2009 Aug; 10(1):80. PubMed ID: 19715610
[TBL] [Abstract][Full Text] [Related]
4. CCL17 acts as an antitumor chemokine in micromilieu-driven immune skewing.
Li Y; Cao H; Jiang Z; Yan K; Shi J; Wang S; Wang F; Wang W; Li X; Sun N; Liu L; Chen L; Chen Y; Guo R; Song Y
Int Immunopharmacol; 2023 May; 118():110078. PubMed ID: 37001380
[TBL] [Abstract][Full Text] [Related]
5. Differential recognition and scavenging of native and truncated macrophage-derived chemokine (macrophage-derived chemokine/CC chemokine ligand 22) by the D6 decoy receptor.
Bonecchi R; Locati M; Galliera E; Vulcano M; Sironi M; Fra AM; Gobbi M; Vecchi A; Sozzani S; Haribabu B; Van Damme J; Mantovani A
J Immunol; 2004 Apr; 172(8):4972-6. PubMed ID: 15067078
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of CCL17, CCL22 and CCR4 in drug-induced maculopapular exanthema.
Tapia B; Morel E; Martín-Díaz MA; Díaz R; Alves-Ferreira J; Rubio P; Padial A; Bellón T
Clin Exp Allergy; 2007 May; 37(5):704-13. PubMed ID: 17456218
[TBL] [Abstract][Full Text] [Related]
7. CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma.
Kumai T; Nagato T; Kobayashi H; Komabayashi Y; Ueda S; Kishibe K; Ohkuri T; Takahara M; Celis E; Harabuchi Y
Cancer Immunol Immunother; 2015 Jun; 64(6):697-705. PubMed ID: 25754123
[TBL] [Abstract][Full Text] [Related]
8. The role of the Th2 CC chemokine ligand CCL17 in pulmonary fibrosis.
Belperio JA; Dy M; Murray L; Burdick MD; Xue YY; Strieter RM; Keane MP
J Immunol; 2004 Oct; 173(7):4692-8. PubMed ID: 15383605
[TBL] [Abstract][Full Text] [Related]
9. [Changes of TRGV genes and prognosis-related chemokine/receptor gene expressions in T cell lymphoma].
Luo Q; Jin Z; Chen S; Yang L; Li B; Li W; Li Y; Wu X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Mar; 33(3):362-366. PubMed ID: 28274317
[TBL] [Abstract][Full Text] [Related]
10. The C-C Chemokines CCL17 and CCL22 and Their Receptor CCR4 in CNS Autoimmunity.
Scheu S; Ali S; Ruland C; Arolt V; Alferink J
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099057
[TBL] [Abstract][Full Text] [Related]
11. CCR4 agonists CCL22 and CCL17 are elevated in pediatric OMS sera: rapid and selective down-regulation of CCL22 by ACTH or corticosteroids.
Pranzatelli MR; Tate ED; McGee NR; Colliver JA; Ransohoff RM
J Clin Immunol; 2013 May; 33(4):817-25. PubMed ID: 23340773
[TBL] [Abstract][Full Text] [Related]
12. Role of CCR4 ligands, CCL17 and CCL22, during Schistosoma mansoni egg-induced pulmonary granuloma formation in mice.
Jakubzick C; Wen H; Matsukawa A; Keller M; Kunkel SL; Hogaboam CM
Am J Pathol; 2004 Oct; 165(4):1211-21. PubMed ID: 15466387
[TBL] [Abstract][Full Text] [Related]
13. Evidence that phospholipase-C-dependent, calcium-independent mechanisms are required for directional migration of T-lymphocytes in response to the CCR4 ligands CCL17 and CCL22.
Cronshaw DG; Kouroumalis A; Parry R; Webb A; Brown Z; Ward SG
J Leukoc Biol; 2006 Jun; 79(6):1369-80. PubMed ID: 16614259
[TBL] [Abstract][Full Text] [Related]
14. Distinct conformations of the chemokine receptor CCR4 with implications for its targeting in allergy.
Viney JM; Andrew DP; Phillips RM; Meiser A; Patel P; Lennartz-Walker M; Cousins DJ; Barton NP; Hall DA; Pease JE
J Immunol; 2014 Apr; 192(7):3419-27. PubMed ID: 24563252
[TBL] [Abstract][Full Text] [Related]
15. Surrogate antibodies that specifically bind and neutralize CCL17 but not CCL22.
Santulli-Marotto S; Fisher J; Petley T; Boakye K; Panavas T; Luongo J; Kavalkovich K; Rycyzyn M; Wu B; Gutshall L; Coelho A; Hogaboam CM; Ryan M
Monoclon Antib Immunodiagn Immunother; 2013 Jun; 32(3):162-71. PubMed ID: 23750473
[TBL] [Abstract][Full Text] [Related]
16. Reduced locomotor activity and exploratory behavior in CC chemokine receptor 4 deficient mice.
Ambrée O; Klassen I; Förster I; Arolt V; Scheu S; Alferink J
Behav Brain Res; 2016 Nov; 314():87-95. PubMed ID: 27469058
[TBL] [Abstract][Full Text] [Related]
17. CCL17 and CCL22 attenuate CCL5-induced mast cell migration.
Juremalm M; Olsson N; Nilsson G
Clin Exp Allergy; 2005 Jun; 35(6):708-12. PubMed ID: 15969658
[TBL] [Abstract][Full Text] [Related]
18. Chemokine receptor 4 expression on blood T lymphocytes predicts severity of major depressive disorder.
Freff J; Beins EC; Bröker L; Schwarte K; Leite Dantas R; Maj C; Arolt V; Dannlowski U; Nöthen MM; Baune BT; Forstner AJ; Alferink J
J Affect Disord; 2022 Aug; 310():343-353. PubMed ID: 35526724
[TBL] [Abstract][Full Text] [Related]
19. CCL17 and CCL22 induce CCR4 receptor expression and promote cytokine-induced killer cells migration.
Dong Y; Gao S; Zhang X; Kou J; Liu J; Ye T; Shen H
Anticancer Drugs; 2022 Feb; 33(2):149-157. PubMed ID: 34657098
[TBL] [Abstract][Full Text] [Related]
20. Engagement of two distinct binding domains on CCL17 is required for signaling through CCR4 and establishment of localized inflammatory conditions in the lung.
Santulli-Marotto S; Boakye K; Lacy E; Wu SJ; Luongo J; Kavalkovich K; Coelho A; Hogaboam CM; Ryan M
PLoS One; 2013; 8(12):e81465. PubMed ID: 24339934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
